SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-003114
Filing Date
2024-02-08
Accepted
2024-02-08 20:01:26
Documents
1
Period of Report
2024-02-06

Document Format Files

Seq Description Document Type Size
1 form4-02092024_010219.html 4  
1 form4-02092024_010219.xml 4 5764
  Complete submission text file 0001415889-24-003114.txt   7239
Mailing Address C/O IGNYTA, INC. 11095 FLINTKOTE AVE., SUITE D SAN DIEGO CA 92121
Business Address
Chacko Jacob (Reporting) CIK: 0001608936 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39269 | Film No.: 24610847

Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Issuer) CIK: 0001796280 (see all company filings)

IRS No.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)